BioCentury
ARTICLE | Company News

PDI Therapeutics Inc., GlaxoSmithKline cancer news

May 30, 2016 7:00 AM UTC

Avalon Ventures launched cancer immunotherapy company PDI Therapeutics as part of an expanded build-to-buy partnership with GlaxoSmithKline. PDI Therapeutics is developing antibodies that inhibit prot...